INTERLEUKIN 5 BINDING PROTEIN DOSAGE REGIMEN

The present disclosure relates to pharmaceutical compositions comprising from about 100 mg to about 300 mg of an antigen binding protein which binds to IL-5. Compositions and antigen binding proteins of the invention are useful in the treatment of IL-5 mediated diseases, such as asthma, and can be a...

Full description

Saved in:
Bibliographic Details
Main Authors BIRD, Nicholas P, MONCK, Myrna A, AUSTIN, Daren J, POULIQUEN, Isabelle J, SHUMAN, Melissa A
Format Patent
LanguageEnglish
French
German
Published 01.11.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to pharmaceutical compositions comprising from about 100 mg to about 300 mg of an antigen binding protein which binds to IL-5. Compositions and antigen binding proteins of the invention are useful in the treatment of IL-5 mediated diseases, such as asthma, and can be administered about once every 6 months.
Bibliography:Application Number: EP20210844228